The ASAC study, Scandinavian multicentre, placebo-controlled, randomized trial, initiated by our group, investigating the role of aspirin as adjuvant after surgery for colorectal liver metastases, is still recruiting patients and has now 300 of 800 patients included (www.asac.no). The trial is funded by Research Council of Norway, Norwegian Cancer Society, and KLINBEFORSK.
EXCALIBUR study; single centre, un-blinded, three-armed randomized trial for patients with high load of colorectal liver metastases, treated with 1)liver transplantation 2)liver resection 3)hepatic artery infusion of chemotherapy. The trial is approved by the Ethical committee and Norwegian Medicinal Agency and will to be initiated in 2021 (www.excaliburstudy.com).
Precision Medicine in Early Diagnostics and Therapy of Biliary Tract Cancer; is a collaborative project between several groups, led by Sheraz Yaqub, started December 2020.
TESLA trial: Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a prospective exploratory trial; this is a collaborative study between several groups at OUH-KIT treating patients with cholangiocarcinoma
CAMINO study: Investigate the value of MRI in assessing CRC liver mets compared to CT scan, and if MRI affects the surgical decision.
Giuliani T, Siriwardena AK, Vollmer CM, Hilal MA, Adham M, Barreto SG, Boggi U, Castillo CF, Del Chiaro M, Falconi M, Friess H, Frigerio I, Fusai GK, Gianotti L, Goh BKP, Halloran CM, Hartwig W, He J, Hogg ME, Jiang K, Katz MHG, Kleeff J, Labori KJ, Lillemoe KD, Pandanaboyana Set al.(2026) The International Study Group for Pancreatic Surgery (ISGPS) Definition and Classification of Postpancreatectomy Mortality Ann Surg(in press) DOI 10.1097/SLA.0000000000007019, PubMed 41572457
Amrutkar M, Guttorm SJT, Labori KJ, Rootwelt H, Elgstøen KBP, Gladhaug IP, Verbeke CS(2026) Reduced lipid metabolite abundance in human pancreatic cancer and matched serum samples following neoadjuvant FOLFIRINOX treatment Metabolomics, 22(1), 18 DOI 10.1007/s11306-025-02388-z, PubMed 41553593
Procopio F, Memeo R, Del Fabbro D, Abdelhadi S, Reissfelder C, Edwin B, Milana F, Troisi RI, Torzilli G, Minimally Invasive R1 Vascular Group(2026) Oncological Adequacy of R1 Vascular Margin in Minimally Invasive Liver Surgery for Hepatocellular Carcinoma and Colorectal Liver Metastases: A Meta-analysis Ann Surg Oncol(in press) DOI 10.1245/s10434-025-18922-1, PubMed 41507450